The phrase "are commonly over" is grammatically correct and can be used in written English.
It can be used to describe situations or conditions that frequently exceed a certain limit or threshold.
Example: "In many cases, the costs of living are commonly over the budget set by the government."
Alternatives: "are often above" or "frequently exceed".
Most previous studies have used participants' self reported heights and weights, which are commonly over and under reported (respectively), leading to systematic underestimation of BMI.
Furthermore the downregulation of DAPK1, TNFRSF11B, TNFSF8, TP73 could be considered as a CR marker: these genes are commonly over expressed in hematopoietic malignancies, but are down regulated in patients after chemotherapy [ 24- 26].
Necroses are also rare in PDAC, whereas mucous gel-forming mucins are commonly over-expressed [9].
In contrast, inhibition of either ALDH1A1 or ALDH3A1 has application in cancer treatments where the isoenzymes are commonly over-expressed and serve as markers for cancer stem cells.
All of these enzymes are commonly over-expressed and activated by inflammation or neoplastic transformation.
IAPs are commonly over-expressed in human cancers [ 12- 14], contributing to the carcinogenic process and to the resistance of these cells to chemotherapy [ 15].
Perhaps this signature represents genes that are commonly over-expressed in breast cancer but do not to fall into a given subtype.
This is particularly relevant in human development and diseases such as cancer in which receptor tyrosine kinases are commonly over-expressed, sometimes by several orders of magnitude.
These proteins are involved in different stages of the metastatic process, and some of them are commonly over-produced in tumors from patients with some of the worst chances of recovery.
Of the growth factor receptors that input signals to ERK1/2 in breast tumour cells, the ErbB/EGFR family of receptor tyrosine kinases is one of the major classes: they are commonly over-expressed (for example, ErbB2 gene amplification occurs in 20 to 30% of tumours [ 19]) or persistently signal (for example, EGFR in tamoxifen resistance [ 83]) in human breast tumours.
Previous CGH studies of NSCLC cell lines and primary tumours have identified chromosomal regions that are commonly over- or under-represented, including gains of 1q, 3q, 5p, 7p and 8q and losses of 3p, 6q, 8p, 9p and 17p (Balsara et al, 1997; Petersen et al, 1997; Björkqvist et al, 1998; Speicher et al, 2000; Luk et al, 2001).
